About
Treatment for Bacterial Infections
Lostam BioPharmaceuticals is developing a novel class of protein therapeutics (biologics) aimed atpreventing and treating lethal Gram-negative bacterial infections associated primarily with the hospital setting.
Identity
| Name | Lostam BioPharmaceuticals |
|---|---|
| Slug | lostam-biopharmaceuticals |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwKW42IoKDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Aug 2016 |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | North District |
| HQ city | Nazareth |
| HQ address | Wadi el-Haj 13, Nazareth, Israel |
Web & social
| https://www.linkedin.com/company/lostam-biopharmaceuticals-ltd |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentBiomaterials & Tissue EngineeringMedical DevicesMedical Treatment & Therapeutics
Technologies
Biologicals
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
biopharmaceuticalbacteriainfectionmedical-technologiestherapeuticsproteinsbiotechnologytreatments
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}